Celtere 80 mg Injection

Celtere 80 mg Injection Specification

Formulations Type
Injectables

Indication
For use in various cancers including breast cancer, non-small cell lung cancer, prostate cancer, gastric cancer, and head and neck cancer.

Storage Instructions
Store in a cool, dry place. Protect from sunlight.

Dosage
As directed by physician

Product Type
Injection

Feature
Sterile, single-dose vial

Treatments & Functions
Anti Cancer

Ingredients
Docetaxel 80mg

Suitable For
Oncology treatment

Use
Hospital, Clinical, Personal

Age Group
Adult

Volume
80 mg/vial

Shelf Life
2 Years

Contraindications
Hypersensitivity to taxanes or polysorbate 80, neutrophil count less than 1,500/mm3

Packaging Type
Vial

Brand Name
Celtere

Physical State
Liquid

Color
Clear to pale yellow solution

Prescription/Non Prescription
Prescription

Hazard Information
For hospital use only. Administer under supervision of qualified healthcare professional.

MRP
As per local regulations

Route of Administration
Intravenous

Celtere 80 mg Injection Trade Information

Supply Ability
1000 Boxes Per Week

Delivery Time
1 Week

About Celtere 80 mg Injection

Experience assertive oncology care with Celtere (Docetaxel 80 mg), a triumph of medical innovation. This opulent, sterile, single-dose vial delivers a clear-to-pale yellow injectable solution for valiant cancer therapy, suitable for breast, lung, gastric, prostate, and head and neck malignancies. Shop now and reserve your supply, ensuring instant checkout for hospital, clinical, or personal applications among adult patients. Exclusively for intravenous administration and available only by prescription, Celtere assures quality, safety, and compliance, adhering to local MRP regulations. For hospital use onlyadminister under expert supervision.

Celtere 80 mg Injection Applications & Usage

Celtere 80 mg Injection is deployed across various hospital, clinical, and personal care settings, primarily for oncology treatments in adults. Used as an injectable solution and reserved for single-dose intravenous administration, it is effective against multiple cancers, including breast, lung, gastric, prostate, and head/neck tumors. Healthcare professionals, hospitals, and specialized clinical staff utilize Celtere to ensure precise, valiant cancer management for their patients.

Supply Capability & Market Certifications for Celtere 80 mg Injection

Our robust supply chain ensures swift availability and secure freight for hospital dealers, distributors, and traders across India. Celtere enjoys main domestic market presence and is approved for supply in hospital networks and clinical institutions. Recognized by stringent certifications, Celtere supports both local and export market demand, ensuring compliant logistics and unprecedented reliability for oncology treatment professionals nationwide.

FAQs of Celtere 80 mg Injection:

Q: How is Celtere 80 mg Injection administered?

A: Celtere 80 mg Injection is administered intravenously by qualified healthcare professionals in hospital or clinical settings, following physician-directed dosage protocols.

Q: What cancers is Celtere 80 mg Injection used to treat?

A: Celtere is indicated for the treatment of various cancers, including breast cancer, non-small cell lung cancer, prostate cancer, gastric cancer, and head and neck cancer.

Q: When should Celtere 80 mg Injection not be used?

A: Celtere should not be administered to patients with hypersensitivity to taxanes or polysorbate 80, or those with a neutrophil count below 1,500/mm.

Q: Where can Celtere 80 mg Injection be sourced?

A: Celtere is available for supply through authorized dealers, distributors, exporters, suppliers, and wholesalers across India, following prescription and regulatory guidelines.

Q: What is the storage process for Celtere 80 mg Injection?

A: Celtere should be stored in a cool, dry place, protected from sunlight, to maintain its efficacy and shelf life of up to 2 years.

Q: How does using Celtere 80 mg Injection benefit cancer patients?

A: Celteres potent formulation offers precise and valiant therapeutic effects, contributing to effective cancer treatment when administered under medical supervision.